NEW YORK CITY, NY / ACCESS Newswire / July 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Vera Bradley, Inc. ("Vera Bradley" or the "Company") (NASDAQ:VRA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Vera Bradley and certain of its […]
NEW YORK CITY, NY / ACCESS Newswire / July 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation ("Neogen" or the "Company") (NASDAQ:NEOG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Neogen and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / July 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of United Natural Foods, Inc. ("United Natural" or the "Company") (NYSE:UNFI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether United Natural and certain of
NEW YORK CITY, NY / ACCESS Newswire / July 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Groupon, Inc. ("Groupon" or the "Company") (NASDAQ:GRPN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Groupon and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / July 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of KBR, Inc. ("KBR" or the "Company") (NYSE:KBR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether KBR and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / July 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ:CAPR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Capricor and certain of its officers and/or
NEW YORK, NY / ACCESS Newswire / July 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Manhattan Associates, Inc. ("Manhattan Associates" or "the Company") (NASDAQ:MANH). Investors who purchased Manhattan Associates securities prior to October 22, 2024, and continue to hold to the present, are encouraged to
NEW YORK CITY, NY / ACCESS Newswire / July 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Novo Nordisk A/S ("Novo Nordisk" or "the Company") (NYSE:NVO). Investors who purchased Novo Nordisk securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s
NEW YORK CITY, NY / ACCESS Newswire / July 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Flux Power Holdings, Inc. ("Flux" or "the Company") (NASDAQ:FLUX). Investors who purchased Flux securities prior to November 11, 2022, and continue to hold to the present, are encouraged to
NEW YORK, NY / ACCESS Newswire / July 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sharecare Inc. ("Sharecare" or "the Company") (NASDAQ:SHCR). Investors who purchased Sharecare securities prior to May 10, 2023, and continue to hold to the present, are encouraged to obtain additional information